Yet another analog of citreamicin known as neocitreamicin I and its derivate neocitreamicin II were reported in 2008 with anti-MRSA MIC at 0

Yet another analog of citreamicin known as neocitreamicin I and its derivate neocitreamicin II were reported in 2008 with anti-MRSA

Continue readingYet another analog of citreamicin known as neocitreamicin I and its derivate neocitreamicin II were reported in 2008 with anti-MRSA MIC at 0

The preprocessing results generated a data matrix that consisted of the retention time (RT), mass-to-charge ratio (m/z) values and peak intensity

The preprocessing results generated a data matrix that consisted of the retention time (RT), mass-to-charge ratio (m/z) values and peak

Continue readingThe preprocessing results generated a data matrix that consisted of the retention time (RT), mass-to-charge ratio (m/z) values and peak intensity

Requirement for HF hospitalization has traditionally been employed as one of several key eligibility criteria in clinical trials to enrich patient risk and to put certainty to a HFpEF diagnosis

Requirement for HF hospitalization has traditionally been employed as one of several key eligibility criteria in clinical trials to enrich

Continue readingRequirement for HF hospitalization has traditionally been employed as one of several key eligibility criteria in clinical trials to enrich patient risk and to put certainty to a HFpEF diagnosis